Anna Schuh
University of Oxford
H-index: 55
Europe-United Kingdom
Top articles of Anna Schuh
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors–an overview and update | Joseph D Khoury Eric Solary Oussama Abla Yassmine Akkari Rita Alaggio | 2022/7 | |
What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms? | Ayoma D Attygalle John KC Chan Sarah E Coupland Ming-Qing Du Judith A Ferry | 2024/4/29 | |
Chronic lymphocytic leukemia therapy guided by measurable residual disease | New England Journal of Medicine | Talha Munir David A Cairns Adrian Bloor David Allsup Kate Cwynarski | 2024/1/25 |
Performance of a liquid biopsy diagnostic prediction model for EBV-positive Burkitt Lymphoma in Sub-Saharan Africa | Blood | Clara C Chamba Kieran Howard William F Mawalla Heavenlight Christopher Julius Seruyange | 2023/11/28 |
P647: RACIAL DISPARITIES IN REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH CLL | HemaSphere | Joanna Rhodes Mazyar Shadman Nicole Lamanna Beenish S Manzoor Catherine Coombs | 2023/8/1 |
LIQUID BIOPSY FOR EARLY, NON‐INVASIVE DIAGNOSIS OF EBV‐POSITIVE BURKITT LYMPHOMA IN RESOURCE LIMITED SETTINGS | Hematological Oncology | CC Chamba P Ntemi A Schuh A Cuts E Balandya | 2023/6 |
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology | Cancer Research | Dylan Domenico Gunes Gundem Max F Levine Juanes E Arango-Ossa Pauline Robbe | 2023/4/4 |
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases | Genome medicine | Alistair T Pagnamenta Carme Camps Edoardo Giacopuzzi John M Taylor Mona Hashim | 2023/11/9 |
Genomic Stratification of Hematological Malignancies | HemaSphere | Pauline Robbe Anna Schuh | 2023/6/1 |
P648: REAL-WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST-LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY | HemaSphere | Frederick Lansigan Toby A Eyre Nilanjan Ghosh Beenish S Manzoor Catherine C Coombs | 2023/8/1 |
Multimodal cell-free DNA whole-genome analysis combined with TET-Assisted Pyridine Borane Sequencing is sensitive and reveals specific cancer signals | medRxiv | Dimitrios V Vavoulis Anthony Cutts Nishita Thota Jordan Brown Robert Sugar | 2023 |
Ibrutinib plus venetoclax with MRD-directed duration of treatment is superior to FCR and is a new standard of care for previously untreated CLL: report of the phase III UK NCRI … | Blood | Peter Hillmen David Allan Cairns Adrian John Clifton Bloor David Allsup Kate Cwynarski | 2023/11/28 |
Differential efficacy from the addition of bortezomib to R-CHOP in diffuse large B-cell lymphoma according to the molecular subgroup in the REMoDL-B study with a 5-year follow-up | Journal of Clinical Oncology | Andrew J Davies Sharon Barrans Louise Stanton Josh Caddy Sam Wilding | 2023/5/5 |
PB1936: IDENTIFYING INEQUITIES IN SUPPORT-GLOBAL SURVEY OF PATIENT ORGANISATIONS DELIVERING SUPPORT SERVICES FOR CLL PATIENTS | HemaSphere | Deborah Baker Nick York Kathryn Huntley Michael Rynne Nicole Schroeter | 2023/8/1 |
Genomic Landscape of Epstein-Barr Virus in Endemic Burkitt Lymphoma | Blood | Ismail D Legason Adam Burns Kate Ridout Daisy Jennings Martin D Ogwang | 2023/11/28 |
Special edition of the Seminars in Hematology series on Global Hematology Care. | Anna Schuh | 2023/9/27 | |
Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa | Clara Chamba Sam M Mbulaiteye Emmanuel Balandya Anna Schuh | 2023/1 | |
Treatment delays in children and young adults with lymphoma: a report from an East Africa lymphoma cohort study | Blood Advances | William Frank Mawalla Liz Morrell Lulu Chirande Caroline Achola Hadija Mwamtemi | 2023/9/12 |
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a … | The Lancet Oncology | Peter Hillmen Alexandra Pitchford Adrian Bloor Angus Broom Moya Young | 2023/5/1 |
Telomere Length and DNA Methylation Epitype Both Provide Independent Prognostic Information in CLL Patients; Data from the UK CLL4, Arctic and Admire Clinical Trials | Blood | Louise J Carr Kevin Norris Helen Parker Anna Nilsson-Takeuchi Dean J Bryant | 2023/11/28 |
